NR565/NR565 MID EXAM Advanced Pharmacology
Questions, Answers and Elaborate
Rationales(100% verified and correct answers )
GRADE A+ Chamberlain 2026/2027
1. A 65-year-old male with type 2 diabetes is prescribed metformin, and you must
understand that its primary mechanism involves inhibition of hepatic gluconeogenesis,
enhancement of peripheral glucose uptake, and improved insulin sensitivity, without
directly stimulating insulin secretion.
A. Sulfonylurea receptor activation
B. SGLT2 inhibition
C. AMPK-mediated hepatic glucose suppression
D. GLP-1 receptor agonism
Correct Answer: C
Rationale: Metformin activates AMP-activated protein kinase (AMPK) in hepatocytes,
suppressing gluconeogenesis, which reduces hepatic glucose output and lowers fasting plasma
glucose. Additionally, it increases insulin-mediated glucose uptake in skeletal muscle and
adipose tissue, improving overall glycemic control. Metformin does not stimulate insulin release,
reducing the risk of hypoglycemia, but gastrointestinal side effects and rare lactic acidosis must
be monitored, especially in renal impairment.
2. A 68-year-old female with heart failure with reduced ejection fraction (HFrEF) is
prescribed carvedilol, and you must recognize that it non-selectively blocks beta-adrenergic
receptors and alpha-1 receptors, decreasing heart rate, myocardial oxygen demand, and
systemic vascular resistance, while providing mortality benefit.
A. Selective beta-1 blockade
B. Non-selective beta-blockade with alpha-1 blockade
C. ACE inhibition only
D. Calcium channel blockade
Correct Answer: B
Rationale: Carvedilol blocks beta-1 and beta-2 receptors to reduce heart rate and contractility,
while alpha-1 blockade decreases systemic vascular resistance, lowering afterload. This
combined effect improves left ventricular function, reduces hospitalizations, and provides
survival benefit in HFrEF. Initiation requires gradual titration to avoid hypotension and
bradycardia, and monitoring for bronchospasm in patients with reactive airway disease is
necessary.
3. A 70-year-old male with chronic gout is prescribed allopurinol, and you must
understand that xanthine oxidase inhibition decreases uric acid synthesis, preventing
monosodium urate crystal deposition, flares, and chronic joint damage.
A. Uricosuric effect
,B. Xanthine oxidase inhibition
C. Cyclooxygenase blockade
D. IL-1 receptor antagonism
Correct Answer: B
Rationale: Allopurinol competitively inhibits xanthine oxidase, reducing conversion of
hypoxanthine and xanthine to uric acid, thereby lowering serum urate levels. This prevents
crystal deposition in joints and tissues, reducing acute attacks and long-term complications such
as tophi and renal stones. Initial therapy may precipitate flares, so prophylactic anti-
inflammatory agents are recommended. Dose adjustment in renal impairment is critical to
prevent toxicity.
4. A 72-year-old female with type 2 diabetes and obesity is prescribed semaglutide, and you
must recognize that its GLP-1 receptor agonist activity enhances glucose-dependent insulin
secretion, suppresses glucagon, slows gastric emptying, and promotes satiety, providing
glycemic and weight benefits.
A. DPP-4 inhibition
B. GLP-1 receptor agonism
C. SGLT2 inhibition
D. Insulin sensitization
Correct Answer: B
Rationale: Semaglutide mimics endogenous GLP-1, enhancing insulin secretion in response to
elevated glucose while suppressing inappropriate glucagon release. Gastric emptying is delayed,
promoting satiety and weight loss. It also provides cardiovascular protection in high-risk
patients. Gastrointestinal side effects are common, and patient education on injection technique
is essential for adherence and efficacy.
5. A 66-year-old male with chronic atrial fibrillation is prescribed dabigatran, and you
must understand that it is a direct thrombin inhibitor, preventing conversion of fibrinogen
to fibrin, reducing stroke and systemic embolism risk.
A. Factor Xa inhibitor
B. Vitamin K antagonist
C. Direct thrombin inhibition
D. Antiplatelet effect
Correct Answer: C
Rationale: Dabigatran directly inhibits thrombin (factor IIa), blocking fibrin formation and
platelet activation. This anticoagulant effect decreases the risk of stroke in non-valvular atrial
fibrillation. Its predictable pharmacokinetics allows fixed dosing without routine monitoring.
Renal function must be assessed prior to initiation due to renal clearance, and bleeding risk
requires patient education on signs of hemorrhage.
6. A 68-year-old female with hyperlipidemia is prescribed atorvastatin, and you must
recognize that it inhibits HMG-CoA reductase, decreasing cholesterol synthesis in
hepatocytes, upregulating LDL receptors, and lowering plasma LDL cholesterol.
A. Bile acid sequestrant
B. HMG-CoA reductase inhibition
C. PCSK9 inhibition
,D. Cholesterol absorption blockade
Correct Answer: B
Rationale: Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol
biosynthesis, leading to reduced intracellular cholesterol and increased LDL receptor expression
on hepatocytes. This enhances LDL clearance from circulation. Statins provide cardiovascular
protection, but monitoring for myopathy, liver function, and drug interactions is necessary,
especially in elderly patients or those on multiple medications.
7. A 70-year-old male with heart failure is prescribed sacubitril/valsartan, and you must
understand that dual inhibition of angiotensin II receptors and neprilysin enhances
natriuretic peptide effects, promotes vasodilation, reduces sodium retention, and mitigates
adverse cardiac remodeling.
A. ACE inhibition only
B. ARB only
C. ARB plus neprilysin inhibition
D. Beta-blockade only
🔵 Correct Answer: C
Rationale: Sacubitril inhibits neprilysin, preventing degradation of beneficial natriuretic
peptides, while valsartan blocks angiotensin II receptors, reducing vasoconstriction and
maladaptive remodeling. This combination improves heart failure outcomes, reduces
hospitalizations, and decreases cardiovascular mortality. Monitoring blood pressure, renal
function, and angioedema risk is essential.
8. A 65-year-old female with chronic kidney disease and hyperphosphatemia is prescribed
sevelamer, and you must recognize that it binds dietary phosphate in the gastrointestinal
tract, lowering serum phosphate and mitigating secondary hyperparathyroidism.
A. Calcium supplementation
B. Phosphate binding
C. Vitamin D analog
D. Loop diuretic
Correct Answer: B
Rationale: Sevelamer binds phosphate in the gut, preventing absorption and reducing serum
phosphate levels. This helps prevent secondary hyperparathyroidism and vascular calcification in
CKD. Its non-calcium formulation avoids hypercalcemia, and proper adherence with meals
maximizes efficacy. Gastrointestinal tolerance should be monitored.
9. A 70-year-old male with COPD is prescribed tiotropium, and you must understand that
its bronchodilatory effect results from long-acting muscarinic receptor antagonism,
preventing acetylcholine-mediated bronchoconstriction.
A. Beta-2 receptor agonism
B. Muscarinic receptor blockade
C. Leukotriene inhibition
D. Phosphodiesterase inhibition
Correct Answer: B
Rationale: Tiotropium selectively blocks M3 muscarinic receptors on airway smooth muscle,
inhibiting cholinergic-mediated bronchoconstriction. Its long-acting effect provides sustained
, bronchodilation with once-daily dosing, improving COPD outcomes and adherence. Correct
inhaler technique is critical to ensure optimal drug delivery and minimize systemic side effects.
10. A 68-year-old male with chronic heart failure is prescribed spironolactone, and you
must recognize that mineralocorticoid receptor antagonism reduces sodium retention,
prevents potassium loss, and mitigates myocardial fibrosis, improving survival and
reducing hospitalization rates.
A. ACE inhibition
B. Beta-blockade
C. Mineralocorticoid receptor antagonism
D. Calcium channel blockade
Correct Answer: C
Rationale: Spironolactone blocks aldosterone-mediated effects on the heart and kidneys,
reducing maladaptive remodeling, sodium retention, and myocardial fibrosis. This improves
morbidity and mortality in HFrEF patients when combined with standard therapy. Hyperkalemia
and renal dysfunction are risks that necessitate regular laboratory monitoring and careful dose
adjustment.
11. A 72-year-old male with atrial fibrillation is prescribed apixaban, and you must
recognize that its direct factor Xa inhibition prevents thrombin generation, fibrin
formation, and thrombus development without requiring routine INR monitoring.
A. Thrombin inhibition
B. Factor Xa inhibition
C. Vitamin K antagonism
D. Antiplatelet effect
Correct Answer: B
Rationale: Apixaban selectively inhibits factor Xa, blocking conversion of prothrombin to
thrombin and preventing clot formation. Its predictable pharmacokinetics allow fixed dosing
without routine monitoring, improving convenience over warfarin. Renal and hepatic function
must be evaluated prior to initiation, and patients should be counseled on bleeding risk and signs
of hemorrhage.
12. A 66-year-old female with chronic neuropathic pain is prescribed pregabalin, and you
must recognize that binding to the alpha-2-delta subunit of voltage-gated calcium channels
reduces excitatory neurotransmitter release, decreasing central sensitization and
neuropathic pain perception.
A. Sodium channel blockade
B. NMDA receptor antagonism
C. Calcium channel modulation
D. Opioid receptor activation
🔵 Correct Answer: C
Rationale: Pregabalin modulates presynaptic calcium channels, decreasing release of
neurotransmitters such as glutamate, norepinephrine, and substance P. This reduces neuronal
hyperexcitability and central sensitization, providing effective neuropathic pain relief. Its non-
opioid mechanism limits addiction potential, though titration is required to minimize dizziness,
somnolence, and edema.
Questions, Answers and Elaborate
Rationales(100% verified and correct answers )
GRADE A+ Chamberlain 2026/2027
1. A 65-year-old male with type 2 diabetes is prescribed metformin, and you must
understand that its primary mechanism involves inhibition of hepatic gluconeogenesis,
enhancement of peripheral glucose uptake, and improved insulin sensitivity, without
directly stimulating insulin secretion.
A. Sulfonylurea receptor activation
B. SGLT2 inhibition
C. AMPK-mediated hepatic glucose suppression
D. GLP-1 receptor agonism
Correct Answer: C
Rationale: Metformin activates AMP-activated protein kinase (AMPK) in hepatocytes,
suppressing gluconeogenesis, which reduces hepatic glucose output and lowers fasting plasma
glucose. Additionally, it increases insulin-mediated glucose uptake in skeletal muscle and
adipose tissue, improving overall glycemic control. Metformin does not stimulate insulin release,
reducing the risk of hypoglycemia, but gastrointestinal side effects and rare lactic acidosis must
be monitored, especially in renal impairment.
2. A 68-year-old female with heart failure with reduced ejection fraction (HFrEF) is
prescribed carvedilol, and you must recognize that it non-selectively blocks beta-adrenergic
receptors and alpha-1 receptors, decreasing heart rate, myocardial oxygen demand, and
systemic vascular resistance, while providing mortality benefit.
A. Selective beta-1 blockade
B. Non-selective beta-blockade with alpha-1 blockade
C. ACE inhibition only
D. Calcium channel blockade
Correct Answer: B
Rationale: Carvedilol blocks beta-1 and beta-2 receptors to reduce heart rate and contractility,
while alpha-1 blockade decreases systemic vascular resistance, lowering afterload. This
combined effect improves left ventricular function, reduces hospitalizations, and provides
survival benefit in HFrEF. Initiation requires gradual titration to avoid hypotension and
bradycardia, and monitoring for bronchospasm in patients with reactive airway disease is
necessary.
3. A 70-year-old male with chronic gout is prescribed allopurinol, and you must
understand that xanthine oxidase inhibition decreases uric acid synthesis, preventing
monosodium urate crystal deposition, flares, and chronic joint damage.
A. Uricosuric effect
,B. Xanthine oxidase inhibition
C. Cyclooxygenase blockade
D. IL-1 receptor antagonism
Correct Answer: B
Rationale: Allopurinol competitively inhibits xanthine oxidase, reducing conversion of
hypoxanthine and xanthine to uric acid, thereby lowering serum urate levels. This prevents
crystal deposition in joints and tissues, reducing acute attacks and long-term complications such
as tophi and renal stones. Initial therapy may precipitate flares, so prophylactic anti-
inflammatory agents are recommended. Dose adjustment in renal impairment is critical to
prevent toxicity.
4. A 72-year-old female with type 2 diabetes and obesity is prescribed semaglutide, and you
must recognize that its GLP-1 receptor agonist activity enhances glucose-dependent insulin
secretion, suppresses glucagon, slows gastric emptying, and promotes satiety, providing
glycemic and weight benefits.
A. DPP-4 inhibition
B. GLP-1 receptor agonism
C. SGLT2 inhibition
D. Insulin sensitization
Correct Answer: B
Rationale: Semaglutide mimics endogenous GLP-1, enhancing insulin secretion in response to
elevated glucose while suppressing inappropriate glucagon release. Gastric emptying is delayed,
promoting satiety and weight loss. It also provides cardiovascular protection in high-risk
patients. Gastrointestinal side effects are common, and patient education on injection technique
is essential for adherence and efficacy.
5. A 66-year-old male with chronic atrial fibrillation is prescribed dabigatran, and you
must understand that it is a direct thrombin inhibitor, preventing conversion of fibrinogen
to fibrin, reducing stroke and systemic embolism risk.
A. Factor Xa inhibitor
B. Vitamin K antagonist
C. Direct thrombin inhibition
D. Antiplatelet effect
Correct Answer: C
Rationale: Dabigatran directly inhibits thrombin (factor IIa), blocking fibrin formation and
platelet activation. This anticoagulant effect decreases the risk of stroke in non-valvular atrial
fibrillation. Its predictable pharmacokinetics allows fixed dosing without routine monitoring.
Renal function must be assessed prior to initiation due to renal clearance, and bleeding risk
requires patient education on signs of hemorrhage.
6. A 68-year-old female with hyperlipidemia is prescribed atorvastatin, and you must
recognize that it inhibits HMG-CoA reductase, decreasing cholesterol synthesis in
hepatocytes, upregulating LDL receptors, and lowering plasma LDL cholesterol.
A. Bile acid sequestrant
B. HMG-CoA reductase inhibition
C. PCSK9 inhibition
,D. Cholesterol absorption blockade
Correct Answer: B
Rationale: Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol
biosynthesis, leading to reduced intracellular cholesterol and increased LDL receptor expression
on hepatocytes. This enhances LDL clearance from circulation. Statins provide cardiovascular
protection, but monitoring for myopathy, liver function, and drug interactions is necessary,
especially in elderly patients or those on multiple medications.
7. A 70-year-old male with heart failure is prescribed sacubitril/valsartan, and you must
understand that dual inhibition of angiotensin II receptors and neprilysin enhances
natriuretic peptide effects, promotes vasodilation, reduces sodium retention, and mitigates
adverse cardiac remodeling.
A. ACE inhibition only
B. ARB only
C. ARB plus neprilysin inhibition
D. Beta-blockade only
🔵 Correct Answer: C
Rationale: Sacubitril inhibits neprilysin, preventing degradation of beneficial natriuretic
peptides, while valsartan blocks angiotensin II receptors, reducing vasoconstriction and
maladaptive remodeling. This combination improves heart failure outcomes, reduces
hospitalizations, and decreases cardiovascular mortality. Monitoring blood pressure, renal
function, and angioedema risk is essential.
8. A 65-year-old female with chronic kidney disease and hyperphosphatemia is prescribed
sevelamer, and you must recognize that it binds dietary phosphate in the gastrointestinal
tract, lowering serum phosphate and mitigating secondary hyperparathyroidism.
A. Calcium supplementation
B. Phosphate binding
C. Vitamin D analog
D. Loop diuretic
Correct Answer: B
Rationale: Sevelamer binds phosphate in the gut, preventing absorption and reducing serum
phosphate levels. This helps prevent secondary hyperparathyroidism and vascular calcification in
CKD. Its non-calcium formulation avoids hypercalcemia, and proper adherence with meals
maximizes efficacy. Gastrointestinal tolerance should be monitored.
9. A 70-year-old male with COPD is prescribed tiotropium, and you must understand that
its bronchodilatory effect results from long-acting muscarinic receptor antagonism,
preventing acetylcholine-mediated bronchoconstriction.
A. Beta-2 receptor agonism
B. Muscarinic receptor blockade
C. Leukotriene inhibition
D. Phosphodiesterase inhibition
Correct Answer: B
Rationale: Tiotropium selectively blocks M3 muscarinic receptors on airway smooth muscle,
inhibiting cholinergic-mediated bronchoconstriction. Its long-acting effect provides sustained
, bronchodilation with once-daily dosing, improving COPD outcomes and adherence. Correct
inhaler technique is critical to ensure optimal drug delivery and minimize systemic side effects.
10. A 68-year-old male with chronic heart failure is prescribed spironolactone, and you
must recognize that mineralocorticoid receptor antagonism reduces sodium retention,
prevents potassium loss, and mitigates myocardial fibrosis, improving survival and
reducing hospitalization rates.
A. ACE inhibition
B. Beta-blockade
C. Mineralocorticoid receptor antagonism
D. Calcium channel blockade
Correct Answer: C
Rationale: Spironolactone blocks aldosterone-mediated effects on the heart and kidneys,
reducing maladaptive remodeling, sodium retention, and myocardial fibrosis. This improves
morbidity and mortality in HFrEF patients when combined with standard therapy. Hyperkalemia
and renal dysfunction are risks that necessitate regular laboratory monitoring and careful dose
adjustment.
11. A 72-year-old male with atrial fibrillation is prescribed apixaban, and you must
recognize that its direct factor Xa inhibition prevents thrombin generation, fibrin
formation, and thrombus development without requiring routine INR monitoring.
A. Thrombin inhibition
B. Factor Xa inhibition
C. Vitamin K antagonism
D. Antiplatelet effect
Correct Answer: B
Rationale: Apixaban selectively inhibits factor Xa, blocking conversion of prothrombin to
thrombin and preventing clot formation. Its predictable pharmacokinetics allow fixed dosing
without routine monitoring, improving convenience over warfarin. Renal and hepatic function
must be evaluated prior to initiation, and patients should be counseled on bleeding risk and signs
of hemorrhage.
12. A 66-year-old female with chronic neuropathic pain is prescribed pregabalin, and you
must recognize that binding to the alpha-2-delta subunit of voltage-gated calcium channels
reduces excitatory neurotransmitter release, decreasing central sensitization and
neuropathic pain perception.
A. Sodium channel blockade
B. NMDA receptor antagonism
C. Calcium channel modulation
D. Opioid receptor activation
🔵 Correct Answer: C
Rationale: Pregabalin modulates presynaptic calcium channels, decreasing release of
neurotransmitters such as glutamate, norepinephrine, and substance P. This reduces neuronal
hyperexcitability and central sensitization, providing effective neuropathic pain relief. Its non-
opioid mechanism limits addiction potential, though titration is required to minimize dizziness,
somnolence, and edema.
